Carbenicillin and gentamicin were tested for synergism against 25 strains of enterococci by two different methods. Killing curves were determined by doing serial colony counts of broth cultures containing the antibiotics separately and in combination. The combination was synergistic for all 25 strains with 75 and 4 ,g of carbenicillin and gentamicin per ml, respectively. Reducing the concentrations to 50 and 3 ug of the antibiotics per ml with four strains significantly reduced the rate of killing of the combination. Synergism was also studied by constructing isobolograms, by using the standard two-dimensional broth dilution checkerboard technique, and by measuring the end points both for minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs). Synergism was present for all 25 strains when bactericidal end points (MBCs) were evaluated, but was present for only 7 of the 25 strains when MICs were used to construct isobolograms. The time and effort involved were roughly the same for killing curves and for isobolograms, and it was concluded that neither had a distinct advantage over the other.
Enterococci are often implicated as causative agents in infections involving the endocardium, abdomen, pelvis, and urinary tract. Combinations of antibiotics, especially penicillins and aminoglycosides, have been found to provide the bactericidal action often required to achieve a clinical cure (16) . The mechanism responsible for this synergistic action involves alteration of permeability of the bacterial cell wall by the penicillin so that the aminoglycoside can penetrate the organism and exert its effect on the ribosomes (18) .
Carbenicillin and gentamicin are frequently administered to patients with presumed sepsis and have been shown to have a synergistic action against Pseudomonas and other gramnegative bacteria (5, 14) . The present study was undertaken to determine in vitro whether carbenicillin and gentamicin in concentrations usually obtained in the blood of patients would show a synergistic, bactericidal action against enterococci. In addition to the usual method of measuring the rate of killing by performing colony counts, synergism was also studied by constructing isobolograms and measuring both bacteriostatic and bactericidal end points. Streptomycin minimal inhibitory cuacentrations (MICs) were also measured to determine the number of strains susceptible to gentamicin but not to streptomycin.
MATERIALS AND METHODS
Antibiotics. Carbenicillin and gentamicin standard powders were supplied by Pfizer, Inc. and Schering Corp., respectively.
Bacteria. Twenty-five strains of enterococci, isolated from a variety of clinical sources, were obtained from the clinical microbiology laboratory at the University of Washington Hospital. They were identified by colonial appearance on blood and MacConkey agar and by their ability to ferment mannitol and reduce 0.1% methylene blue milk. The strains were grown in Mueller Hinton Broth (MHB) prior to use and streaked onto blood and MacConkey agar to check for contamination before testing.
Media. Mueller Hinton broth (Difco) adjusted to pH 7.4 was used for cultures and serial dilutions of the antibiotics and bacteria.
Synergism as determined by killing curves. Serial colony counts were performed with broth cultures of the 25 strains of enterococci to determine the time-related bactericidal effects of carbenicillin and gentamicin alone and in combination (3, 7) . A 1-ml portion of a 10-2 dilution of an overnight culture was added to 9 ml of broth containing one or both antibiotics to give an average final inoculum of 4. (6, 12) .
Variations of one tube in MICs and MBCs are commonly observed with serial dilution tests, and one-tube differences have a marked effect on the shape of the isobologram. As a result, some investigators have defined synergism as at least a two-tube (fourfold) reduction of the MIC or MBC of both antibiotics (4, 10, 17 ,ug/ml) is not enhanced by combining this antibiotic with penicillin G (8, 13) . On the other hand, strains highly resistant to gentamicin have not been described, and synergism of this antibiotic with penicillin G has invariably been present (9, 15) . It seemed of interest, therefore, to determine how many of our 25 strains were resistant to streptomycin and to see if there was any cross-resistance with gentamicin. Mueller Hinton agar (Difco), adjusted to pH 7.4, was used to make plates containing twofold serial dilutions of streptomycin in concentrations from 1,024 to 4 Ag/ml and to make a plate without antibiotic as a control. The Steers replicator device was then used to transfer 0.001 to 0.002 ml of a 102 dilution of an overnight culture of each strain onto the surface of the agar plates. The lowest concentration of streptomycin permitting growth of no more than one colony was called the MIC, an end point that has become commonly accepted for the agar dilution technique because of the occurrence of occasional resistant mutants (2, 11 (Fig. 2) . Furthermore, colony counts with the three strains showing synergism did not decrease to below 100 CFUs, a marked contrast to the results obtained with the higher antibiotic concentrations described above where all 25 strains showed complete killing (reduction to the lowest counts measurable). Synergism as determined by isobolograms. By using the criteria described above, isobolograms obtained by plotting MBCs of the antibiotics combined in different ratios showed synergism against all 25 strains, agreeing completely with the results of the killing curves. Indeed, for 24 of the 25 strains the reduction was much greater than the minimal requirement of a fourfold lowering of the MBCs for both antibiotics. In contrast, synergism was present for only 7 of the 25 strains when bacteriostatic rather than bactericidal end points were used to construct the isobolograms. With 14 strains the 
DISCUSSION
It has become well established that enterococcal infections, especially endocarditis, are most likely to respond to synergistic combinations of antibiotics. Synergism has been shown to occur against 60% of strains of enterococci when they are exposed to penicillin G in combination with streptomycin, 80% with penicillin and kanamycin, and 100% with penicillin and gentamicin (8, 9, 15) . Carbenicillin and gentamicin were shown in the present study to The demonstration of synergism by killing curves is time consuming, and alternative methods might be preferable. Therefore, attempts were made to correlate the results of killing curves with the other widely used method of measuring synergism, namely, the construction of isobolograms by using broth dilution tests in which the two antibiotics are combined in 144 tubes in a large variety of concentrations, the so-called checkerboard technique (6, 12, 17) . Both MICs and MBCs were used to construct isobolograms, and with the latter synergism was present with all 25 strains, a perfect correlation with the results of killing curves. On the other hand, there was synergism with only 7 of the 25 strains when MICs were used as the end points. McCracken et al. did observe synergism against 10 strains of enterococci when MICs were used as the basis for isobolograms. Although their criteria for synergism were less stringent than ours, this does not fully explain the difference, because synergism would be present with only 68% of our strains if the criteria of McCracken et al. were used. Because isobolograms using MBCs correlated with killing curves as noted above, the technique could serve as an alternative method for detecting synergy, although the time and effort were not appreciably less.
The mechanism responsible for synergism against enterococci is probably the same with carbenicillin as for penicillin G and ampicillin, namely, it increases the permeability to the aminoglycoside and thereby facilitates its action on the ribosomes (18) . None of our strains was highly resistant to gentamicin, and none has been described so far (9) . On the other hand, high-level resistance to streptomycin, present with 40% of our 25 strains, is associated with a lack of synergistic activity, presumably because the organisms are resistant at the ribosomal level even when significant intracellular concentrations are reached (18) . This may be because the large, single-step mutations commonly encountered with streptomycin occur rarely, if ever, with gentamicin.
The cost of carbenicillin and the difficulty in maintaining adequate blood levels for long periods of time would make it impractical to treat infections known to be caused only by enterococci with carbenicillin and gentamicin. It this study indicates that under these circumstances effective antibacterial activity against enterococci should be present.
